Hashimoto’s thyroiditis is diagnosed through a combination of blood tests that measure thyroid hormone levels and specific antibodies attacking the thyroid gland. In most cases, a simple blood draw is enough to confirm the diagnosis, though ultrasound and occasionally biopsy play a role when results are unclear or nodules are present.
The Blood Tests That Confirm Hashimoto’s
The diagnostic process typically starts with two categories of blood work: thyroid function tests and thyroid antibody tests. Together, they paint a clear picture of both how well your thyroid is working and whether your immune system is the reason it’s struggling.
Thyroid function is assessed through TSH (thyroid-stimulating hormone) and free T4 (thyroxine). TSH is the most sensitive early indicator. When your thyroid starts to underperform, your pituitary gland pumps out more TSH to compensate, so TSH rises before your actual thyroid hormone levels drop. A TSH between roughly 5 and 10 mIU/L with normal T4 suggests subclinical hypothyroidism, meaning your thyroid is struggling but still keeping up. A TSH above 10 mIU/L, or a low T4, indicates overt hypothyroidism with symptoms you can feel.
Because TSH fluctuates, an abnormal result on a single test isn’t always definitive. Clinicians typically repeat testing over three to six months to confirm persistently abnormal levels before making a diagnosis.
Antibody Tests: The Autoimmune Fingerprint
What separates Hashimoto’s from other causes of hypothyroidism is the presence of antibodies directed against your own thyroid tissue. Two antibodies are tested: thyroid peroxidase antibodies (TPO antibodies) and thyroglobulin antibodies (TgAb).
TPO antibodies are the primary marker. They’re positive in over 90% of people with Hashimoto’s. Mayo Clinic Laboratories considers anything above 9.0 IU/mL elevated, and values above that threshold are generally associated with autoimmune thyroiditis. Thyroglobulin antibodies are positive in roughly 80% of cases and serve as a backup test. When both antibodies are measured together, 97% of Hashimoto’s patients will test positive for at least one of them.
Higher antibody levels tend to correlate with more active disease, though the numbers themselves don’t predict how severe your symptoms will be or how quickly your thyroid function will decline. Some people carry elevated antibodies for years before their TSH becomes abnormal.
What Happens When Antibodies Are Negative
About 3% of people with Hashimoto’s test negative for both TPO and thyroglobulin antibodies. This is called seronegative Hashimoto’s, and it’s one of the trickier diagnostic scenarios. In these cases, a thyroid ultrasound becomes essential. Diagnostic criteria established in 2020 define seronegative Hashimoto’s as negative antibodies combined with subclinical or overt hypothyroidism and a characteristic pattern of diffuse hypoechogenicity (darker-than-normal tissue) on ultrasound. That dark appearance on imaging reflects lymphocytic infiltration, the hallmark of the immune system attacking the gland, and can serve as an early diagnostic marker even before antibodies become detectable.
The Role of Thyroid Ultrasound
Ultrasound isn’t required for every Hashimoto’s diagnosis. If your blood work clearly shows elevated TSH plus positive antibodies, the picture is complete. But ultrasound becomes valuable in several situations: when antibodies are negative, when your doctor feels an enlarged or lumpy thyroid during a physical exam, or when nodules need to be evaluated.
On ultrasound, a thyroid affected by Hashimoto’s typically appears darker and more uneven in texture than a healthy gland. Nodules are common. When they appear, the most frequent patterns are solid hypoechoic nodules (27% of cases), solid nodules surrounded by a thin dark halo (23%), and complex cystic nodules (20%). About 20% of Hashimoto’s nodules contain calcifications. The appearance is variable enough that ultrasound alone can’t confirm the diagnosis, but combined with blood work, it adds a useful layer of information.
When a Biopsy Is Needed
Fine needle aspiration, a biopsy where a thin needle draws a small sample of thyroid cells, is not part of the standard Hashimoto’s workup. It’s reserved for cases where a nodule looks suspicious on ultrasound and needs to be checked for thyroid cancer. The procedure is quick, safe, and accurate for distinguishing Hashimoto’s-related nodules from something more concerning. People with Hashimoto’s have a slightly higher rate of thyroid nodules, which is why suspicious ones are investigated rather than assumed benign.
Conditions That Look Like Hashimoto’s
Several thyroid conditions share overlapping features with Hashimoto’s, and part of the diagnostic process involves ruling them out.
Postpartum thyroiditis is one of the closest mimics. It can cause elevated TPO antibodies and even looks similar under a microscope. The key difference is its timeline and behavior. Postpartum thyroiditis typically starts with a brief hyperthyroid (overactive) phase within the first year after delivery, characterized by low TSH and elevated thyroid hormones. In Graves’ disease, another autoimmune thyroid condition, a specific antibody called TSH receptor antibody (TRAb) is present. This antibody stimulates the thyroid rather than destroying it. Testing for TRAb helps distinguish Graves’ from Hashimoto’s when the clinical picture is ambiguous, particularly if someone has symptoms of an overactive thyroid or thyroid eye disease.
Who Should Get Tested
The U.S. Preventive Services Task Force does not recommend routine thyroid screening for adults without symptoms. But certain risk factors make testing worthwhile if you’re experiencing fatigue, weight gain, cold sensitivity, brain fog, constipation, or other signs of an underperforming thyroid.
You’re at higher risk if you’re female, older, have type 1 diabetes or another autoimmune condition, have a family history of thyroid disease, have Down syndrome, have a visible goiter, or have had radiation to the head and neck area. If any of these apply and you’re noticing symptoms, a TSH test is a reasonable first step. From there, your results will determine whether antibody testing and further evaluation are needed.
What the Diagnosis Actually Looks Like
In practice, most Hashimoto’s diagnoses follow a straightforward path. You report symptoms or a routine blood panel catches an elevated TSH. Your doctor orders a follow-up TSH along with TPO antibodies. If TSH is persistently elevated and TPO antibodies are positive, that’s typically enough for a diagnosis. The whole process can take anywhere from a single visit to several months if your doctor wants to confirm that abnormal TSH levels aren’t a temporary fluctuation.
Once diagnosed, the focus shifts to monitoring. Not everyone with Hashimoto’s needs treatment right away. People with subclinical hypothyroidism (mildly elevated TSH, normal T4) are often monitored with periodic blood tests to see whether their thyroid function declines further. Those with overt hypothyroidism, where TSH is significantly elevated and T4 has dropped, generally begin thyroid hormone replacement. Either way, the same blood tests used for diagnosis become the tools for tracking the condition over time.